EUROBIO-SCIENTIFIC (ALERS.PA) Forecast, Price Target & Analyst Ratings

EPA:ALERS • FR0013240934

Current stock price

22.15 EUR
0 (0%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EUROBIO-SCIENTIFIC (ALERS.PA).

Forecast Snapshot

Consensus Price Target

Price Target
€30.60
+ 38.15% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 10, 2026
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.44%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€30.60
Upside
+ 38.15%
From current price of €22.15 to mean target of €30.60, Based on 9 analyst forecasts
Low
€30.30
Median
€30.60
High
€31.50

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for ALERS.PA. The average price target is 30.6 EUR. This implies a price increase of 38.15% is expected in the next year compared to the current price of 22.15.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ALERS Current Analyst RatingALERS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

ALERS Historical Analyst RatingsALERS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
84.44%
ALERS.PA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ALERS.PA.
In the previous month the buy percentage consensus was at a similar level.
ALERS.PA was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 10, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026
Revenue
YoY % growth
ALERS.PA revenue by date.ALERS.PA revenue by date.
152.607M
-17.38%		130.003M
-14.81%		154.562M
18.89%		173.45M
12.22%		181.18M
4.46%
EBITDA
YoY % growth
ALERS.PA ebitda by date.ALERS.PA ebitda by date.
40.094M
-47.97%		28.788M
-28.20%		30.669M
6.53%		28.531M
-6.97%		33.372M
16.97%
EBIT
YoY % growth
ALERS.PA ebit by date.ALERS.PA ebit by date.
30.869M
-55.98%		14.539M
-52.90%		13.615M
-6.36%		24.514M
80.05%		29.355M
19.75%
Operating Margin
ALERS.PA operating margin by date.ALERS.PA operating margin by date.
20.23%11.18%8.81%14.13%16.20%
EPS
YoY % growth
ALERS.PA eps by date.ALERS.PA eps by date.
N/A
-60.93%		N/A
-60.35%		N/A
-2.22%		0.80
-11.36%		1.16
44.87%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ALERS.PA Yearly Revenue VS EstimatesALERS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
ALERS.PA Yearly EPS VS EstimatesALERS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

EUROBIO-SCIENTIFIC / ALERS.PA Forecast FAQ

What is the average price target for EUROBIO-SCIENTIFIC (ALERS.PA) stock?

9 analysts have analysed ALERS.PA and the average price target is 30.6 EUR. This implies a price increase of 38.15% is expected in the next year compared to the current price of 22.15.

What is the next earnings date for ALERS stock?

EUROBIO-SCIENTIFIC (ALERS.PA) will report earnings on 2026-04-10.

What is the number of analysts for ALERS stock?

The number of analysts covering EUROBIO-SCIENTIFIC (ALERS.PA) is 9.